Sevil Korkmaz-Icöz1, Shiliang Li2, Regina Hüttner2, Mihály Ruppert2, Tamás Radovits3, Sivakkanan Loganathan4, Alex Ali Sayour2, Paige Brlecic2, Felix Lasitschka5, Matthias Karck2, Gábor Szabó2. 1. Department of Cardiac Surgery, Heidelberg University Hospital, Heidelberg, Germany. Electronic address: korkmaz_sevil@hotmail.com. 2. Department of Cardiac Surgery, Heidelberg University Hospital, Heidelberg, Germany. 3. Heart and Vascular Center, Semmelweis University, Budapest, Hungary. 4. Department of Cardiac Surgery, Heidelberg University Hospital, Heidelberg, Germany; Department of Anesthesiology, Ruhr University Bochum, St. Josef- and St. Elisabeth Hospital, Bochum, Germany. 5. Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
Abstract
BACKGROUND: Heart transplantation is the definitive treatment for end-stage heart failure. A shortage of donor hearts forced transplant programs to accept older donors and longer ischemic times. Previous studies have suggested that administration of mesenchymal stem cells (MSCs) or their conditioned medium (CM) protects the heart against ischemia/reperfusion injury (IRI). We hypothesized that the preservation of donor hearts with a CM would protect the graft from IRI after prolonged storage in 15-month-old rats and investigated mRNA changes attributable to CM. METHODS: Rat MSCs were isolated and cultured. The CM was used and characterized by a 90-antibody array, revealing the presence of 28 factors involved in apoptosis, inflammation, and oxidative stress. Hearts from 15-month-old donor rats were explanted and continuously perfused for 5 hours with oxygenated, 4°C cardioplegic solution, and supplemented with either regular cell culture medium (control group) or CM. The hearts were then heterotopically transplanted. We evaluated in-vivo left ventricular graft function 1.5 hours after transplantation and the myocardial expression of 120 genes using polymerase chain reaction arrays. RESULTS: Systolic contractility and relaxation parameters were significantly reduced in 15-month-old rats compared with the young rats. After transplantation, systolic function (dP/dtmax: 1,197 ± 94 vs 1,825 ± 279 mm Hg/s at 140 µl; p < 0.05) and diastolic function (dP/dtmin: 737 ± 168 vs 1,200 ± 166 mm Hg/s at 140 µl, p < 0.05) were significantly improved in the CM group compared with controls. Among the genes surveyed, the expressions of 66 were altered. Genes of pro-inflammatory cytokines and interleukins were down-regulated, whereas expression of the anti-oxidant gene superoxide dismutase-2 was up-regulated in the CM-treated grafts compared with the control group grafts. CONCLUSIONS: Perfusion of donor hearts with CM protects against myocardial IRI in 15-month-old rats.
BACKGROUND: Heart transplantation is the definitive treatment for end-stage heart failure. A shortage of donor hearts forced transplant programs to accept older donors and longer ischemic times. Previous studies have suggested that administration of mesenchymal stem cells (MSCs) or their conditioned medium (CM) protects the heart against ischemia/reperfusion injury (IRI). We hypothesized that the preservation of donor hearts with a CM would protect the graft from IRI after prolonged storage in 15-month-old rats and investigated mRNA changes attributable to CM. METHODS:Rat MSCs were isolated and cultured. The CM was used and characterized by a 90-antibody array, revealing the presence of 28 factors involved in apoptosis, inflammation, and oxidative stress. Hearts from 15-month-old donorrats were explanted and continuously perfused for 5 hours with oxygenated, 4°C cardioplegic solution, and supplemented with either regular cell culture medium (control group) or CM. The hearts were then heterotopically transplanted. We evaluated in-vivo left ventricular graft function 1.5 hours after transplantation and the myocardial expression of 120 genes using polymerase chain reaction arrays. RESULTS: Systolic contractility and relaxation parameters were significantly reduced in 15-month-old rats compared with the young rats. After transplantation, systolic function (dP/dtmax: 1,197 ± 94 vs 1,825 ± 279 mm Hg/s at 140 µl; p < 0.05) and diastolic function (dP/dtmin: 737 ± 168 vs 1,200 ± 166 mm Hg/s at 140 µl, p < 0.05) were significantly improved in the CM group compared with controls. Among the genes surveyed, the expressions of 66 were altered. Genes of pro-inflammatory cytokines and interleukins were down-regulated, whereas expression of the anti-oxidant gene superoxide dismutase-2 was up-regulated in the CM-treated grafts compared with the control group grafts. CONCLUSIONS: Perfusion of donor hearts with CM protects against myocardial IRI in 15-month-old rats.
Authors: Susan R Scott; Keith L March; I-Wen Wang; Kanhaiya Singh; Jianyun Liu; Mark Turrentine; Chandan K Sen; Meijing Wang Journal: J Mol Cell Cardiol Date: 2021-11-11 Impact factor: 5.000
Authors: Bradley W Ellis; Dmitry O Traktuev; Stephanie Merfeld-Clauss; Uryan Isik Can; Meijing Wang; Ray Bergeron; Pinar Zorlutuna; Keith L March Journal: Stem Cells Date: 2020-12-23 Impact factor: 6.277
Authors: Sevil Korkmaz-Icöz; Xiaoxin Sun; Shiliang Li; Paige Brlecic; Sivakkanan Loganathan; Mihály Ruppert; Alex Ali Sayour; Tamás Radovits; Matthias Karck; Gábor Szabó Journal: Cells Date: 2021-05-17 Impact factor: 6.600
Authors: Sevil Korkmaz-Icöz; Pengyu Zhou; Yuxing Guo; Sivakkanan Loganathan; Paige Brlecic; Tamás Radovits; Alex Ali Sayour; Mihály Ruppert; Gábor Veres; Matthias Karck; Gábor Szabó Journal: Stem Cell Res Ther Date: 2021-02-24 Impact factor: 6.832
Authors: William R Critchley; John P Stone; Qiuming Liao; Guangqi Qin; Ivar Risnes; Andrew Trafford; Helge Scott; Trygve Sjöberg; Stig Steen; James E Fildes Journal: Front Immunol Date: 2020-07-28 Impact factor: 7.561
Authors: Mindaugas Kvietkauskas; Bettina Leber; Kestutis Strupas; Philipp Stiegler; Peter Schemmer Journal: Front Immunol Date: 2020-02-27 Impact factor: 7.561